WHWK · Forms 3, 4, 5
Insider trades at Whitehawk Therapeutics, Inc.
No open-market insider buys or sells at Whitehawk Therapeutics, Inc. in the last 90 days; 8 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Whitehawk Therapeutics, Inc. (WHWK) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| David James Lennon | CHIEF EXECUTIVE OFFICER | Options or other derivatives | Form 4 | ||||
| Scott M. Giacobello | CHIEF FINANCIAL OFFICER | Options or other derivatives | Form 4 | ||||
| Margaret Dugan | Chief Medical Officer | Options or other derivatives | Form 4 | ||||
| David Dornan | Chief Scientific Officer | Options or other derivatives | Form 4 | ||||
| Bryan Ball | Officer | Options or other derivatives | Form 4 | ||||
| Vijay K Iyengar | Director | Options or other derivatives | Form 4 | ||||
| Vijay K Iyengar | Director | Became an insider (Form 3) | Form 3 | ||||
| Anupam Dalal | Director | Award | 1,275,510 | $3.92 | $5M | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.